Waycross Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Waycross Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 1, 2024	Karius	$100.0M Series C	Khosla Ventures, Andrew Booth	Coalition Operators, NanoDimension, Pareto Holdings, Seventure Partners, WorkLife Ventures, Ysios Capital, Andy Coravos, Claire Hughes Johnson, Blue Water Life Science Advisors, General Catalyst, HBM Healthcare Investments, Innovation Endeavors, Vali Barsan
Sep 1, 2022	Delphinus Medical Technologies	$30.0M Series D	—	Beringea, Galen Partners, Paul McCreadie, Hopen Life Science Ventures, North Coast Technology Investors, Venture Investors
Oct 1, 2021	Neumora Therapeutics	$400.0M Series A	ARCH Venture Partners	Deerfield Management, Flagship Ventures, F-Prime Capital Partners, Samsung Ventures, T1D Fund, Alexandria Venture Investments, Altitude Life Science Ventures, Catalio Capital Management, Stacie Weninger, Invus, Logos Capital, Mubadala Capital, Newpath Partners, Polaris Partners, re.Mind Capital, SoftBank, Surveyor Capital
Sep 1, 2015	Delphinus Medical Technologies	$40.0M Series C	John Neis	Beringea, Galen Partners, Arboretum Ventures, Hopen Life Science Ventures, North Coast Technology Investors
Feb 9, 2015	Verana Health	$7.8M Series B	—	Boris Nikolic, GE Ventures, Lagunita BioSciences